Lung Desease Models Core
肺部疾病模型核心
基本信息
- 批准号:7476122
- 负责人:
- 金额:$ 21.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAirway ResistanceAllergensAllergicAnimal ModelAnimalsAntigensAsthmaBiochemicalBiologyBreedingCell CountChronicComputersDataDevelopmentDiseaseDisease modelEndotoxinsEnvironmental PollutantsEosinophiliaEvaluationExposure toFormalinFreezingGenesGeneticGoalsHarvestHistologyHumanImmunobiologyIndividualInflammationInterventionLaboratory miceLipidsLungLung InflammationLung Lavage FluidLung diseasesMeasurableMeasurementMeasuresMechanicsMessenger RNAMissionModelingMolecularMouse StrainsMucous body substanceMusNational Institute of Allergy and Infectious DiseaseNumbersObstructionParalysedPathogenesisPeripheralPhasePhenotypePhysiologicalProductionProteinsProtocols documentationPublic HealthRangeResearch PersonnelResistanceResourcesRoleSerumServicesSignal PathwayStructure of parenchyma of lungTechnical ExpertiseTestingTissue BanksTissuesToxic effectTransgenic OrganismsVentilatorWild Type MouseWorkairway hyperresponsivenessairway inflammationairway remodelingdesignembryonic stem cellenvironmental agentgenetic technologyhuman diseasehuman studyimprovedin vivointerestmethacholinemouse modelnovelprotein expressionresponse
项目摘要
The long-term objective of this core is to provide investigators interested in environmental lung disease the
resources and technical expertise required to conduct in vivo mechanistic studies in mice. The following
core services will be provided: 1) importation and exportation of mice, 2) breeding of wild type mice for
mechanistic studies, 3) breeding and genotying of genetically manipulated mouse lines for use in
mechanistic studies, 4) development of allergic mice using both acute and chronic sensitization/challenge
protocols, 5) exposure of animals to model environmental pollutants, 6) treatment interventions to test the
efficacy, toxicity, and mechanisms of action of novel therapies, and 7) physiological phenotyping of mice
after the induction of environmental lung disease for evaluation of airway resistance, compliance, and airway
hyperresponsiveness to methacholine. This core supports the mission of NIAID to study genetic and
environmental interactions as they relate to environmental lung disease. Mechanistic studies in animals,
particularly the use of genetically manipulated mice, is essential for the development of new therapies to
improve public health.
该核心的长期目标是为对环境肺部疾病感兴趣的研究人员
在小鼠中进行体内机械研究所需的资源和技术专长。下列
将提供核心服务:1)进口和出口小鼠,2)野生型小鼠的育种
机械研究,3)遗传操纵小鼠系的繁殖和基因构成用于用于
机械研究,4)使用急性和慢性敏化/挑战的过敏小鼠的发展
方案,5)动物暴露于建模环境污染物,6)治疗干预措施以测试
新疗法的功效,毒性和作用机制,以及7)小鼠的生理表型
诱导环境肺部疾病以评估气道阻力,合规性和气道
对甲基胆碱的反应性过高。该核心支持NIAID的使命研究遗传和
与环境肺部疾病有关的环境相互作用。动物的机械研究,
特别是使用遗传操纵小鼠的使用,对于开发新疗法至关重要
改善公共卫生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN Lloyd TILLEY其他文献
STEPHEN Lloyd TILLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN Lloyd TILLEY', 18)}}的其他基金
Adenosine receptors as therapeutic targets for chronic rhinosinusitis
腺苷受体作为慢性鼻窦炎的治疗靶点
- 批准号:
8415507 - 财政年份:2012
- 资助金额:
$ 21.24万 - 项目类别:
相似国自然基金
CBCT下颅面结构对上气道形态及鼻阻力影响的研究
- 批准号:81400062
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
阻塞性睡眠呼吸暂停综合征上游气道结构改变对下游气道塌陷性的影响机制
- 批准号:81371079
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Th1/Th17 Immune Regulation in Severe Allergic Asthma
严重过敏性哮喘中的 Th1/Th17 免疫调节
- 批准号:
10348780 - 财政年份:2021
- 资助金额:
$ 21.24万 - 项目类别:
Th1/Th17 Immune Regulation in Severe Allergic Asthma
严重过敏性哮喘中的 Th1/Th17 免疫调节
- 批准号:
10214803 - 财政年份:2021
- 资助金额:
$ 21.24万 - 项目类别:
Isoprenoid Biology in Asthma: Proof-of-Principle and Method Development
哮喘中的类异戊二烯生物学:原理验证和方法开发
- 批准号:
9810509 - 财政年份:2019
- 资助金额:
$ 21.24万 - 项目类别: